Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 800 results for "msd r n"

IPL: After CSK Skipper MSD, Coach Stephen Fleming joins Pune too
Odisha Samaya

MSD to lead Rising Pune in IPL

ted overs skipper Mahendra Singh Dhoni was named captain of Rising Pune Supergiants, owned by Sanjiv Goenka, for the upcoming season of the Indian Premier League here on Monday. Unveiling the team logo and captain, team owner Sanjiv Goenka said: ... New Delhi Pioneer, 3 weeks ago

2 images for "msd r n"

Octafinance, 3 weeks ago
Odisha Samaya, 4 weeks ago
Deccan Chronicle

MSD overstaying his time as skipper: Chappell

ralia captain Ian Chappell feels Mahendra Singh Dhoni is overstaying his time as India's limited over skipper and it is having debilitating effect on the Indian team. One tendency a successful captain has to guard against is outstaying his ...
 New Delhi Pioneer2 weeks ago Twitterati celebrate as Mahendra Singh Dhoni's daughter Ziva turns 1  ZeeNews.com2 days ago IPL 2016: Pune bats for MS Dhoni and hopes for his magical r …  Yahoo! India1 month ago Indian Premier League​: New franchises separate MS Dhoni, Suresh Raina  ZeeNews.com1 month ago
Pharmafile

Merck Announces Fourth-Quarter and Full-Year 2015 Financial Results

KENILWORTH, N.J.--( BUSINESS WIRE )--Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced financial results for the fourth quarter and full year of 2015. "The past year was one of considerable progress and ...
 FierceBiotech3 days ago WHO to Review Merck's Investigational Ebola Vaccine for EUAL  PharmaAsia2 weeks ago Data for KEYTRUDA® (pembrolizumab) in a Range of Gastrointestinal Cancers to be Presented at 2016 Gastrointestinal Cancers Symposium  BioMedReports2 weeks ago Merck to pay $830 mn to resolve class action case over Vioxx  PharmaBiz3 weeks ago
[x]  
5 Dariya News - English

Chief Secretary discusses MsD Plan for Minority blocks of J&K

The State Level Committee for the implementation of Multi Sectoral Development Programme (MsDP) headed by Chief Secretary, B R Sharma Tuesday discussed the proposed MsD Plan for Minority Blocks of Leh district and Nowshera Block of district ...
 5 Dariya News - English3 weeks ago CS discusses MsD Plan for minority blocks of JK  Rising Kashmir3 weeks ago

WuXi AppTec Congratulates MSD on Receiving FDA Approval of ZEPATIER(TM)

SHANGHAI, Feb. 2, 2016 /PRNewswire/ -- WuXi AppTec (WuXi), a leading open-access R&D capability and technology platform company serving the global pharmaceutical, biotechnology, and medical device industries, congratulates MSD, known as Merck & Co., ...
 TickerTech.com6 days ago WUXI PHARMATECH CAYMAN : AppTec Congratulates MSD on Receiving FDA Approval of Zepatier  4 Traders4 days ago WuXi AppTec Congratulates On Receiving FDA Approval Of ZEPATIER  BioSpace5 days ago Merck Receives Approval of ZEPATIER (elbasvir/grazoprevir) in Canada for the Treatment of Chronic Hepatitis C for Patients with Genotype 1, 3, or 4 Infection Following Priority Review  Canada NewsWire5 days ago
[x]  

S'porean man sues NZ ministry over pension

A Singaporean based in New Zealand has taken the country's Ministry of Social Development (MSD) to court for reducing his pension benefits there by the amount he gets from his Central Provident Fund (CPF) deposits here. He even tried to include ...
 Asiaone2 weeks ago
Broadway World

MOSEDA TECHNOLOGIES : Announces Appointment of Experienced Healthcare Technology Executive

VANCOUVER, BRITISH COLUMBIA--(Marketwired - Jan. 18, 2016) - Moseda Technologies Inc. (TSX VENTURE:MSD) ("Moseda" or the "Company"), a technology company focused on developing progressive mobile health (mHealth) and telemedicine solutions for ...
 4 Traders3 weeks ago Moseda Announces Appointment of Experienced Healthcare Technology Executive  Yahoo! Finance UK and Ireland3 weeks ago MOSAID TECHNOLOGIES : Moseda Announces Appointment of Experienced Healthcare Technology Executive  4 Traders3 weeks ago
[x]  

Complix Enters into Strategic Collaboration with MSD to Develop Cell-Penetrating Alphabodies to Treat Cancer

/PRNewswire/ -- Complix to receive upfront fees, research funding, and milestone payments Complix, a biopharmaceutical company developing a pipeline of transformative protein therapeutics, called Alphabodies, for the treatment of cancer and severe ...
 TickerTech.com1 month ago
[x]  

MSD and GAVI agree Ebola vaccine deal

MSD and the global vaccine alliance Gavi have agreed a deal to provide 300,000 dosesof an Ebola virus vaccine, to continue trials and begin preparation for future outbreaks of the deadly virus. The deal, announced today at the World Economic Forum ...
 Pharmafile2 weeks ago Merck signs agreement with Gavi for purchase commitment of Ebola vaccine  Financial Express2 weeks ago Merck and Gavi sign purchase commitment for Ebola vaccine  Financial Express2 weeks ago Ebola vaccine purchasing commitment from Gavi to prepare for future outbreaks  Noodls2 weeks ago
[x]  
European Pharmaceutical Review

Gavi Vaccines Alliance in deal with Merck & Co for Ebola vaccine

Gavi, the Vaccine Alliance, has signed an agreement with the MSD subsidiary of US pharma giant Merck & Co (NYSE: MRK) to support the provision of a vaccine to protect against future deadly Ebola outbreaks. The agreement, announced today at the ...
 Pharma Letter2 weeks ago Gavi funds Merck's development of Ebola vaccine  European Pharmaceutical Review2 weeks ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less